BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3460220)

  • 1. HLA antigens and complotypes in insulin-dependent diabetes mellitus.
    Partanen J; Koskimies S; Ilonen J; Knip M
    Tissue Antigens; 1986 May; 27(5):291-7. PubMed ID: 3460220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland.
    Ilonen J; Surcel HM; Partanen J; Koskimies S; Knip M; Käär ML
    Tissue Antigens; 1988 Sep; 32(3):139-44. PubMed ID: 3217930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes.
    Rich SS; Weitkamp LR; Barbosa J
    Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
    Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
    de Jongh BM; Bruining GJ; Schreuder GM; Schuurman RK; Radder JK; van Loghem E; Meera Khan P; Hauptmann G; van Rood JJ
    Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies.
    Murphy CC; Acton RT; Barger BO; Go RC; Kirk KA; Reitnauer PJ; Roseman JM
    Clin Genet; 1983 Jun; 23(6):405-14. PubMed ID: 6411398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
    Thomsen M; Mølvig J; Zerbib A; de Preval C; Abbal M; Dugoujon JM; Ohayon E; Svejgaard A; Cambon-Thomsen A; Nerup J
    Immunogenetics; 1988; 28(5):320-7. PubMed ID: 3139557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HLA, A, B, C, DR, C4, Bf in insulin-dependent diabetics in the Tunisian population].
    Jenhani F; Bardi R; Gorgi Y; Ayed K; Chammaki S; Boukhris R
    Ann Biol Clin (Paris); 1989; 47(1):23-8. PubMed ID: 2648900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
    Kelly H; McCann VJ; Kay PH; Dawkins RL
    Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.
    McCluskey J; McCann VJ; Kay PH; Zilko PJ; Christiansen FT; O'Neill GJ; Dawkins RL
    Diabetologia; 1983 Mar; 24(3):162-5. PubMed ID: 6573286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A; Ohayon E; Hauptmann G; Sevin A; Abbal M; Sommer E; Vergnes H; Ducos J
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus.
    Platz P; Jakobsen BK; Morling N; Ryder LP; Svejgaard A; Thomsen M; Christy M; Kromann H; Benn J; Nerup J; Green A; Hauge M
    Diabetologia; 1981 Aug; 21(2):108-15. PubMed ID: 6167481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and insulin-dependent juvenile diabetes mellitus.
    Májský A; Dvoráková L
    Czech Med; 1983; 6(3):152-8. PubMed ID: 6416792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians.
    Mercier P; Vallo JJ; Vialettes B; Vague P
    Tissue Antigens; 1985 Jul; 26(1):20-4. PubMed ID: 3875911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
    Citro M; Gadaleta G; Gamba Ansaldi S; Molinatti M; Salvetti E; Bruni B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):108-42. PubMed ID: 6388459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.